KKR & Co. Inc. (NYSE:KKR) Releases Quarterly Earnings Results, Beats Estimates By $0.35 EPS

KKR & Co. Inc. (NYSE:KKR) posted its earnings results on Thursday. The asset manager reported $1.38 EPS for the quarter, beating analysts’ consensus estimates of $1.03 by $0.35, Briefing.com reports. The company had revenue of $4.79 billion during the quarter, compared to analysts’ expectations of $1.23 billion. KKR & Co. Inc. had a net margin of 17.99% and a return on equity of 5.05%. During the same quarter in the prior year, the company posted $0.73 earnings per share.

KKR & Co. Inc. Stock Performance

Shares of NYSE KKR traded down $3.40 during trading on Friday, reaching $139.88. 2,866,224 shares of the company traded hands, compared to its average volume of 2,444,026. The firm’s fifty day simple moving average is $128.49 and its 200 day simple moving average is $114.00. The stock has a market cap of $124.14 billion, a P/E ratio of 32.99, a PEG ratio of 1.20 and a beta of 1.62. KKR & Co. Inc. has a 12-month low of $53.72 and a 12-month high of $147.15. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.86.

KKR & Co. Inc. Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, November 19th. Shareholders of record on Monday, November 4th will be issued a $0.175 dividend. This represents a $0.70 annualized dividend and a yield of 0.50%. The ex-dividend date of this dividend is Monday, November 4th. KKR & Co. Inc.’s payout ratio is 16.51%.

Insider Activity

In related news, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of the firm’s stock in a transaction dated Friday, September 13th. The stock was sold at an average price of $25.75, for a total transaction of $149,350,000.00. Following the sale, the insider now directly owns 25,260,971 shares of the company’s stock, valued at $650,470,003.25. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of the stock in a transaction on Friday, September 13th. The shares were sold at an average price of $25.75, for a total transaction of $149,350,000.00. Following the sale, the insider now directly owns 25,260,971 shares of the company’s stock, valued at approximately $650,470,003.25. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, major shareholder Kkr Group Partnership L.P. purchased 11,619,998 shares of the company’s stock in a transaction that occurred on Wednesday, September 11th. The shares were purchased at an average price of $11.13 per share, for a total transaction of $129,330,577.74. Following the transaction, the insider now owns 92,959,984 shares of the company’s stock, valued at $1,034,644,621.92. This trade represents a 0.00 % increase in their position. The disclosure for this purchase can be found here. Insiders own 39.34% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on KKR. StockNews.com raised KKR & Co. Inc. to a “sell” rating in a research report on Friday. Deutsche Bank Aktiengesellschaft upped their target price on KKR & Co. Inc. from $128.00 to $141.00 and gave the company a “buy” rating in a research report on Thursday, August 1st. JMP Securities raised their price target on KKR & Co. Inc. from $135.00 to $150.00 and gave the stock a “market outperform” rating in a report on Wednesday, October 9th. TD Cowen upped their price objective on shares of KKR & Co. Inc. from $166.00 to $184.00 and gave the company a “buy” rating in a report on Friday. Finally, Argus upgraded shares of KKR & Co. Inc. to a “strong-buy” rating in a research note on Thursday, August 1st. One analyst has rated the stock with a sell rating, two have issued a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, KKR & Co. Inc. has a consensus rating of “Moderate Buy” and a consensus price target of $151.29.

KKR & Co. Inc. Company Profile

KKR & Co Inc is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market and middle market investments.